AMICUS THERAPEUTICS, INC. — Director's Dealing 2025

Jan 6, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2025-01-02

Reporting Person: Rosenberg Ellen (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-01-02	Common Stock	F	6442	$9.31	Disposed	377777	Direct
2025-01-03	Common Stock	A	112495	—	Acquired	490272	Direct
2025-01-03	Common Stock	F	15397	$9.41	Disposed	474875	Direct
2025-01-04	Common Stock	F	3381	$9.41	Disposed	471494	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-01-03	Stock Options (right to buy)	$9.41	A	203825	Acquired	2035-01-03	Common Stock (203825)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	15000	Indirect

Footnotes

F1: Granted in the form of Restricted Stock Units ("RSUs"), these RSUs will vest in four equal annual installments beginning on January 3, 2026 and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock.

F2: These options vest and become exercisable in a series of installments over a four year period with 25% vesting one year after the date of grant and the remaining 75% vesting ratably each month thereafter.